Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03557320
Other study ID # API/2012/29
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 31, 2013
Est. completion date June 30, 2014

Study information

Verified date January 2020
Source Centre Hospitalier Universitaire de Besancon
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study aims to evaluate the association between spontaneous pneumothorax onset and weather parameters.


Description:

The aim of this study is to analyse the relation between onset of the PSP and exposure to environmental factors such as atmospheric pressure.

A case-crossover epidemiological study will be conducted in 14 French hospitals. SP recorded from 2009 to 2013 will be exhaustively included. Demographic and clinical characteristics will be collected. For each incident case of SP, the period of occurrence of the event (case period) will be compared to several other periods temporally distant from the case period (control periods prior to and after the event). Exposure will be assessed using meteorological stations localized in the vicinity of each patient's home. A potential threshold effect and/or time lag effect between exposure and admission for SP will be explored.

The results of this study will help to identify the meteorological factors associated with the occurrence of SP, and to deepen our knowledge of the pathophysiological mechanisms of SP especially the influence of meteorological factors on bleb rupture.


Recruitment information / eligibility

Status Completed
Enrollment 3090
Est. completion date June 30, 2014
Est. primary completion date June 30, 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age over 18 years

- first episode of primary spontaneous pneumothorax

Exclusion Criteria:

- Patients with traumatic

- Patients with secondary pneumothorax

- Patients with recurrent pneumothorax and patients with short-term readmissions (recurrence was defined as a new ED admission for the same diagnosis more than 14 days after the first admission).

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France CHU Angers Angers
France Centre Hospitalier de Belfort Belfort
France CH Boulogne sur Mer Boulogne sur Mer
France CHU Clermont Ferrand Clermont Ferrand
France CHU Dijon Dijon
France Polyclinique de DIVION Divion
France Clinique de HENIN BEAUMONT Henin Beaumont
France CH Lomme Lomme
France CH Mulhouse Mulhouse
France CHU Nimes Nimes
France CHU Poitiers Poitiers
France CHU Toulouse Toulouse
France Centre Hospitalier de Vesoul Vesoul

Sponsors (15)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Besancon Centre Hospitalier de Bethune, Centre Hospitalier de Boulogne sur Mer, Centre Hospitalier de la Haute Saone, Centre Hospitalier de Roubaix, Centre Hospitalier Saint Philibert Lomme, Centre Hospitalier Universitaire de Angers, Centre Hospitalier Universitaire de Nimes, Centre Hospitalier Universitaire de Saint Etienne, Centre Hospitalier Universitaire Dijon, CHU de Reims, Groupe Hospitalier de la Region de Mulhouse et Sud Alsace, Hôpital Nord Franche-Comté, Poitiers University Hospital, University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Estimate odds ratio for the association between meteorological data and onset of PSP. 28 days
See also
  Status Clinical Trial Phase
Recruiting NCT02916992 - Prevalence of Spontaneous Pneumothorax in BHD Phase 1
Completed NCT05861037 - Thoracoscopy for Idiopathic Pneumothorax in Children
Recruiting NCT01848860 - Absorbable Mesh Pleurodesis in Thoracoscopic Treatment of Spontaneous Pneumothorax Phase 2/Phase 3
Completed NCT02573285 - Spontaneous Pneumothorax in Children N/A
Completed NCT02030795 - Techniques for Lung Deflation With Arndt® Blocker Phase 2
Recruiting NCT04758143 - Most Preventable Surgical Option to Reduce Primary Spontaneous Pneumothorax Patients' Postoperative Recurrence: A Prospective Cohort Study